Earlier quoted context omitted.
It‘s interesting to see how negative the comments are here, compared to the civil disobedience of SciHub — in fact it‘s much of the same thing. And while there is an argument to be made about how developing new medicine costs real money, the re-investment of profits into research is around 10%, we‘re talking about a deeply corrupt industry here. And while it‘s definitely still morally questionable to clone new drugs,…
> It‘s interesting to see how negative the comments are here, compared to the civil disobedience of SciHub — in fact it‘s much of the same thing. Those things are worlds apart, in my view. Pharmaceutical companies add serious value to the world. They expend enormous amounts of money researching and testing drugs, and then shepherding them through the obscenely expensive FDA approval process. Journal publishers like E…
I'll go further and suggest that their clone of the EpiPen is ingenious, and entirely without moral concern. If the available commodity technology makes it this easy, we're stupid to not take advantage of it. It can't violate patents of the EpiPen since that's all expired.
With developmental drugs like cabotegravir, the patent question comes into play. But also, there is basically zero enforcement requested by these drug companies for the online distribution of unauthorized Chinese and Indian suppliers of thousands of pre-approval experimental drugs. Literally nobody cares.